Profiles
“Wild ride”: Opus Medical’s COO on improving cancer treatment as his startup goes global
Harnessing technology more than a decade in the making, the medical minds behind Opus Medical are pursuing a global opportunity exceeding $800 million to improve treatment outcomes for breast cancer patients. Co-founded by Dr Sean Pollock (COO) and University of Sydney Professor Paul Keall (Director), the Sydney-based medtech startup is in the business of developing […]
